Economic burden of asthma: a systematic review
摘要:
p pBackground/p pAsthma is associated with enormous healthcare expenditures that include both direct and indirect costs. It is also associated with the loss of future potential earnings related to both morbidity and mortality. The objective of the study is to determine the burden of disease costs associated with asthma./p pMethods/p pWe performed a systematic search of MEDLINE, EMBASE, CINAHL, CDSR, OHE-HEED, and Web of Science Databases between 1966 and 2008./p pResults/p pSixty-eight studies met the inclusion criteria. Hospitalization and medications were found to be the most important cost driver of direct costs. Work and school loss accounted for the greatest percentage of indirect costs. The cost of asthma was correlated with comorbidities, age, and disease severity./p pConclusion/p pDespite the availability of effective preventive therapy, costs associated with asthma are increasing. Strategies including education of patients and physicians, and regular follow-up are required to reduce the economic burden of asthma./p
展开
关键词:
Humans Bronchoalveolar Lavage Fluid Cystic Fibrosis Bronchitis, Chronic Acute Disease Pulmonary Surfactant-Associated Protein B Pulmonary Surfactant-Associated Protein C Case-Control Studies Down-Regulation Adolescent
DOI:
10.1186/1471-2466-9-24
被引量:
年份:
2009













































































通过文献互助平台发起求助,成功后即可免费获取论文全文。
相似文献
参考文献
引证文献
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用!